LogoThe Drop In by DoubleBlind
Upgrade
Subscribe Now
LogoThe Drop In by DoubleBlind

Archive

💧 Is ayahuasca a performance-enhancing drug?

Nov 4, 2024

•

14 min read

💧 Is ayahuasca a performance-enhancing drug?

PLUS, Mega doses of mushrooms and healing women in the forest

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 Who is opposing psychedelic legalization in Mass... and why?

Oct 31, 2024

•

13 min read

💧 Who is opposing psychedelic legalization in Mass... and why?

PLUS, Q&A with researchers about spiritual transformation in therapy

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 Why Buffy actress’ career pivot matters to all of us

Oct 28, 2024

•

12 min read

💧 Why Buffy actress’ career pivot matters to all of us

PLUS, The legal “leaf of the gods” that can induce lucid dreams

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 The Shipibo healers fighting against exploitation

Oct 24, 2024

•

13 min read

💧 The Shipibo healers fighting against exploitation

PLUS, How to find (good) underground raves

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧Should tech CEO’s be guiding the psychedelic movement?

Oct 21, 2024

•

14 min read

💧Should tech CEO’s be guiding the psychedelic movement?

PLUS, East Forest’s new mushroom music documentary

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 Research reveals a better approach to psychedelic therapy

Oct 17, 2024

•

12 min read

💧 Research reveals a better approach to psychedelic therapy

PLUS, the perils of bad music while tripping

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 Why the "Psychedelic Renaissance" risks repeating history

Oct 14, 2024

•

12 min read

💧 Why the "Psychedelic Renaissance" risks repeating history

PLUS, Indigenous oral history of plant medicines

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 Serpents and jaguars and ayahuasca—oh my!

Oct 10, 2024

•

12 min read

💧 Serpents and jaguars and ayahuasca—oh my!

PLUS, the wild-west of ketamine telehealth

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧You could qualify for psilocybin therapy, study suggests

Oct 7, 2024

•

13 min read

💧You could qualify for psilocybin therapy, study suggests

PLUS, Berlin clinic offers support to those after challenging trips

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 Meet the most iconic LSD blotters in history

Oct 3, 2024

•

12 min read

💧 Meet the most iconic LSD blotters in history

PLUS, Congress wants your thoughts on psychedelics

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 Dennis McKenna fights for coca

Sep 30, 2024

•

12 min read

💧 Dennis McKenna fights for coca

PLUS, shroom company's CEO arrested for fraud

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 Dogs, LSD, and autism

Sep 26, 2024

•

12 min read

💧 Dogs, LSD, and autism

PLUS, meet the "Blue Dream" of shrooms

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
1...232425262728
The Drop In by DoubleBlind

The Drop In by DoubleBlind

Your essential newsletter covering the world of psychedelics. Trusted by 100k+ readers.


Home

Account